Journal ArticleDOI
One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men.
Reads0
Chats0
TLDR
The results of this naturalistic study indicate that chemical castration is associated with a significant rise in the plasma levels of Abeta and, clinically, with increased depression and anxiety scores.About:
This article is published in Psychoneuroendocrinology.The article was published on 2004-09-01. It has received 240 citations till now. The article focuses on the topics: Chemical castration & Castration.read more
Citations
More filters
Journal ArticleDOI
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
Andrew M.D. Wolf,Richard C. Wender,Ruth B. Etzioni,Ian M. Thompson,Anthony V. D'Amico,Robert J. Volk,Durado Brooks,Chiranjeev Dash,Idris Guessous,Idris Guessous,Idris Guessous,Kimberly S. Andrews,Carol DeSantis,Robert A. Smith +13 more
TL;DR: It is recommended that asymptomatic men who have at least a 10‐year life expectancy have an opportunity to make an informed decision with their health care provider about screening for prostate cancer after they receive information about the uncertainties, risks, and potential benefits associated with prostate cancer screening.
Journal ArticleDOI
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
TL;DR: This scientific statement synthesizes available information on the medical consequences of P ED use, identifies gaps in knowledge, and aims to focus the attention of the medical community and policymakers on PED use as an important public health problem.
Journal ArticleDOI
Changes in neuronal activation patterns in response to androgen deprivation therapy: a pilot study
TL;DR: Findings, while preliminary, suggest that ADT reduces task-related neural activation in brain regions that are involved in mental rotation and accurate recall of spatial information.
Journal ArticleDOI
Gonadal steroid hormones and the hypothalamo–pituitary–adrenal axis
TL;DR: The make up of the HPA axis and hypothalamo-pituitary-gonadal (HPG) axis is examined and the interactions between the two that should be considered when exploring normal and pathological responses to environmental stressors are examined.
Journal ArticleDOI
Testosterone and depression: systematic review and meta-analysis.
TL;DR: TT may have an antidepressant effect in depressed patients, especially those with hypogonadism or HIV/AIDS and elderly subpopulations, and the route by which TT is administered may play a role in treatment response.
References
More filters
Journal ArticleDOI
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
Jacques E. Rossouw,Garnet L. Anderson,Ross L. Prentice,Andrea Z. LaCroix,Charles Kooperberg,Marcia L. Stefanick,Rebecca D. Jackson,Shirley A.A. Beresford,Barbara V. Howard,Karen C. Johnson,Jane Morley Kotchen,Judith K. Ockene +11 more
TL;DR: Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women, and the results indicate that this regimen should not be initiated or continued for primary prevention of CHD.
Journal ArticleDOI
An inventory for measuring clinical anxiety: psychometric properties.
TL;DR: Un nouvel inventaire auto-administre destine a mesurer l'anxiete pathologique, le «Beck Anxiety Cheklist» (BAI) est decrit, evalue et compare au «Hamilton Anxiety Rating Scale» (test avec lequel des correlations moderees sont trouvees).
Book ChapterDOI
Wechsler Adult Intelligence Scale-III
Joseph J. Ryan,Shane J. Lopez +1 more
TL;DR: The Wechsler Adult Intelligence Scale-III (wais-iii) as mentioned in this paper is the most recent version of the W-B I (W-B II) and was published in 2003.
Journal ArticleDOI
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
Ming-Xin Tang,Diane M. Jacobs,Yaakov Stern,Karen Marder,Peter W. Schofield,Barry J. Gurland,Howard Andrews,Richard Mayeux +7 more
TL;DR: Oestrogen use in postmenopausal women may delay the onset and decrease the risk of Alzheimer's disease and Prospective studies are needed to establish the dose and duration required to provide this benefit and to assess its safety in elderly post menopause women.